Condensed Consolidated Statements of Operations (Unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017	Jun. 30, 2016
Revenues:
Product sales	$ 7,886	$ 2,110	$ 15,680	$ 4,212
Product royalty revenues	613	394	2,273	1,328
Research and development reimbursements	245		267	4
Contract revenues		2,500	20,000	2,500
Total Revenues:	8,744	5,004	38,220	8,044
Cost of sales	4,171	4,094	9,816	6,644
Expenses:
Research and development	1,590	4,008	4,260	9,385
Selling, general and administrative	15,970	12,496	29,227	25,551
Total Expenses:	17,560	16,504	33,487	34,936
Loss from operations	(12,987)	(15,594)	(5,083)	(33,536)
Interest expense	(1,878)	(914)	(4,764)	(1,691)
Derivative gain		22		22
Other expense, net	(14)		(15)	(14)
Bargain purchase gain			27,336
(Loss) income before income taxes	(14,879)	(16,486)	17,474	(35,219)
Income tax benefit			15,972
Net (loss) income attributable to common stockholders	$ (14,879)	$ (16,486)	$ 33,446	$ (35,219)
Basic
Basic (loss) income per share:	$ (0.27)	$ (0.31)	$ 0.61	$ (0.66)
Weighted average common stock shares outstanding:	55,388,774	53,594,979	54,949,901	53,412,813
Diluted
Diluted (loss) income per share:	$ (0.27)	$ (0.31)	$ 0.60	$ (0.66)
Diluted weighted average common stock shares outstanding:	55,388,774	53,594,979	55,836,769	53,412,813